Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis

Journal of Hepatology

Volumn 24, Issue 5, 1996, Pages 574-580

  Basili, Stefania ^a   Ferro, Domenico ^a   Leo, Roberto ^a   Juliano, Luigi ^a   Alessandri, Cesare ^a   Cordova, Corrado ^a   Violi, Francesco ^a,b   Quintarelli, C ^c   Vezza, E ^c   Saliola, M ^c   Lugara G ^c   Vieri, Marco ^c   Cara, D ^c   Massafra, S ^c   Pettirossi, G ^c   Paradiso, M ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

^c NONE

Author keywords

Bleeding time; Cirrhosis; Hemorrhage

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLEEDING TIME; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

EID: 0029970145     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80143-7     Document Type: Article

References (31)

1. Rodgers RPC. A critical reappraisal of bleeding time. Semin Thromb Haemost 1990; 16: 1-20.
2. Blake JC, Sprengers D, Greech P, McCormick PA, McIntyre N, Burroughs AK. Bleeding time in patients with hepatic cirrhosis. Br Med J 1990; 301: 12-5.
3. Violi F, Leo R, Vezza E, Basili S, Cordova C, Balsano F, CALC Group. Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. J Hepatol 1994; 20: 531-6.
4. Rubin MH, Weston MJ, Langley PG, White Y, Williams R. Platelet function in chronic liver disease. Relationship to disease severity. Dig Dis Sci 1979; 24: 197-202.
5. Violi F, Leo R, Davì G, Praticò D, Juliano L, Balsano F. Thrombocytopenia and thrombocytopathia in liver cirrhosis. Platelets 1992; 3: 233-9.
6. Stein SF, Harker LA. Kinetic and functional studies of platelets, fibrinogen and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 1982; 99: 217-30.
7. Laffi G, Cominelli F, La Villa G, Fedi S, Pinzani M, Meacci E, Gentilini P. Reduced platelet Thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. In: Samuelsson B, Paoletti R, Ramwell PW. Advances in Prostglandins, Thromboxane and Leukotriene Research, Vol.17. New York: Raven Press, 1987: 366-9.
8. Owen JS, Hutton RCD, Bruckdorfer KR, McIntyre N. Platelet lipid composition and platelet aggregation in human liver disease. J Lipid Res 1981; 22: 423-30.
9. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-9.
10. The North Italian Endoscopic Club for the study and treatment of oesophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and oesophageal varices. N Engl J Med 1988; 319: 983-9.
11. Pinto C, Abratentes A, Esteves AV, Almeida M, Pinto Correia J. Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am J Gastroenterol 1989; 84: 1239-43.
12. Audhuy B, Doffoel M, Wiesel ML, Hemmendinger S, Carenave JP, Bockel R. Importance des troubles de l'hemostase primaire dans la survenue des hemorrhagies digestives hautes du cirrotique. Ann Gastroenterol Hepatol 1884; 20: 177-82.
13. Violi F, Leo R, Basili S, Ferro D, Cordova C, Balsano F, and the CALC Group. Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study. Haematologica 1994; 79: 31-5.
14. Poynard T, Calès P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D, and the FIMS Group. Beta-adrenergic antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and oesophageal varices. N Engl J Med 1991; 324: 1532-8.
15. Pugh RNH, Murray-Lyon IM, Dawson JL. Transection of oesophagus for bleeding oesophagus varices. Br J Surg 1973; 60: 646-9.
16. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1987.
17. Mannucci PM, Man D. Hemostatic problems in liver disease. Haematologica 1981; 66: 233-48.
18. Violi F, Ferro D, Quintarelli C, Saliola M, Cordova C, Balsano F. Clotting abnormalities in chronic liver disease. Dig Dis 1992; 10: 162-72.
19. Carr JM. Disseminated intravascular coagulation in cirrhosis. Hepatology 1989; 10: 103-10.
20. Ferro D, Quintarelli C, Saliola M, Alessandri C, Basili S, Bonavita MS, Violi F. Prevalence of hyperfibrinolysis in patients with liver cirrhosis. Fibrinolysis 1992; 6: 1-4.
21. Boks AL, Brommer EJP, Schalm SW, Van Vliet HHDM. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage. Hepatology 1986; 6: 79-86.
22. Violi F, Ferro D, Basili S, Quintarelli C, Saliola M, Alessandri C, Cordova C, Balsano F. Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis. Hepatology 1992; 12: 672-4.
23. Thomas DP, Ream J, Stuart RK. Platelet aggregation in patient with Laennec's cirrhosis of the liver. N Engl J Med 1967; 276: 1344-8.
24. Desai K, Mistry P, Bagget C, Burroughs AK, Bellamy MF, Owen JS. Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis. Lancet 1989; i: 693-5.
25. Laffi G, Marra F, Gresele P, Romagnoli P, Palermo A, Bartolini O, Simoni A, Orlandi L, Selli ML, Nenci GG, Gentilini P. Evidence for storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992; 103: 641-6.
26. Laffi G, Marra F, Failli P, Ruggiero M, Cecchi E, Carloni V, Giotti A, Gentilini P. Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. Gastroenterology 1993; 105: 148-56.
27. Francis JL, Armstrong DJ. Acquired dysfibrinogenemia in liver disease. J Clin Pathol 1982; 35: 667-72.
28. Lipinski B, Lipinska I, Nowak A, Gurewich V. Abnormal fibrinogen heterogenity and fibrinolytic activity in advanced liver disease. J Lab Clin Med 1977; 90: 187-94.
29. Piccinino F, Sagnelli P, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2: 165-75.
30. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547-52.
31. Bernardi MM, Califf RM, Kleiman N, Ellis SG, Topol EJ for the TAMI Group. Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. Am J Cardiol 1993; 72: 1121-5.